Article • Dean Baker’s Beat the Press
Drugs are Cheap if Patents Don’t Make Them Expensive: The Medicines for the People Act
Publicly funded drug research—like the system proposed in Rep. Rashida Tlaib’s bill—could replace patent monopolies, reducing prices and corruption while still supporting innovation.